Antitumor effect of Streptococcus pyogenes by inducing hydrogen peroxide production

Japanese Journal of Cancer Research

Volumn 87, Issue 12, 1996, Pages 1271-1279

  Higuchi, Yoshihiro ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiutmor effect; Hydrogen peroxide; Natural killer cells; OK 432; Streptococcus pyogenes

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROGEN PEROXIDE; PICIBANIL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HEMOLYSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

EID: 0030453772     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03143.x     Document Type: Article

References (34)

1. Higuchi, Y., Kigoshi, S. and Shoin, S. Comparative experiments with hemolytic streptococcus and its anticancer preparations (OK-431 and OK-432) for their cytolytic activity. Jpn. J. Exp. Med., 50, 7-12 (1980).
2. Okamoto, H., Minami, M., Shoin, S., Koshimura, S. and Shimizu, R. On the streptococcal preparation having potent anticancer activity. Jpn. J. Exp. Med., 36, 175-186 (1966).
3. Taketo, Y. and Taketo, A. Oncolytic activity in vitro of streptococci with special reference to cell bound hemolysin. J. Biochem., 61, 450-459 (1967).
4. Ginsburg, I. and Harris, T. N. Oxygen-stable hemolysins of group A streptococci IV. Studies on the mechanisms of lysis by cell-bound hemolysin of red blood cells and Ehrlich ascites tumor cells. J. Exp. Med., 121, 647-656 (1965).
5. Havas, H. F., Donnelly, A. J. and Porreca, A. V. The cytolytic effects of hemolytic streptococci on ascites tumor cells. Cancer Res., 23, 700-706 (1963).
6. Bernheimer, A. W. Formation of a bacterial toxin (streptolysin S) by resting cells. J. Exp. Med., 90, 373-392 (1949).
7. Oshimi, K., Kano, S., Takaku, F. and Okumura, K. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. J. Natl. Cancer Inst., 65, 1265-1269 (1980).
8. Uchida, A. and Micksche, M. In vitro augmentation of natural killing activity by OK-432. Int. J. Immunopharm., 3, 365-375 (1981).
9. Ishii, Y., Yamaoka, H., Toh, K. and Kikuchi, K. Inhibition of tumor growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432. Gann, 67, 115-119 (1976).
10. Murayama, T., Natsuume-Sakai, S., Ryoyama, K. and Koshimura, S. Studies of the properties of a streptococcal preparation, OK-432, as an immunopotentiator, II. Mechanism of macrophage activation by OK-432. Cancer Immunol. Immunother., 12, 141-146 (1982).
11. Kondo, M., Ikegami, M., Imanishi, H., Nishigaki, I., Hosokawa, K. and Masuda, M. Streptococcal preparation as an activator of host-mediated immune response; cellular immunity and alternate pathway of complement. Gann, 66, 675-678 (1975).
12. Matsubara, S., Suzuki, F. and Ishida, N. Induction of immune interferon in mice treated with a bacterial immunopotentiator, OK-432. Cancer Immunol. Immunother., 6, 41-45 (1979).
13. Wakasugi, H., Kusahara, T., Minato, N., Hamuro, J., Miyata, M. and Morioka, Y. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432. J. Natl. Cancer Inst., 69, 807-812 (1982).
14. Welsh, M. J., Shasby, D. M. and Husted, R. M. Oxidants 1278 increase paracellular permeability in a cultured epithelial cell line. J. Clin. Invest., 76, 1155-1168 (1985).
15. Hinshaw, D. B., Sklar, L. A., Bohl, B., Schraufstatter, I. U., Hyslop, P. A., Rossi, M. W., Spragg, R. D. and Cochrane, C. G. Cytoskeletal and morphologic impact of cellular oxidant injury. Am. J. Pathol., 123, 454-464 (1986).
16. Doroshow, J. H. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc. Natl. Acad. Sci. USA, 83, 4514-4518 (1986).
17. Nathan, C. F. and Cohn, Z. A. Antitumor effects of hydrogen peroxide in vivo. J. Exp. Med., 154, 1539-1553 (1981).
18. Hyslop, P. A., Hinshaw, D. B., Halsey, W. A. Jr., Schraufstatter, I. U., Sauerheber, R. D., Spragg, R. D., Jackson, J. H. and Cochrane, C. G. Mechanisms of oxidant-mediated cell injury; the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J. Biol. Chem., 263, 1665-1675 (1988).
19. Green, H. N. and Westrop, L. W. Hydrogen peroxide and tumor therapy. Nature, 181, 128-129 (1958).
20. Higuchi, Y., Shoin, S. and Matsukawa, S. Enhancement of the antitumor effect of glucose oxidase by combined administration of hydrogen peroxide decomposition inhibitors together with an oxygenated fluorocarbon. Jpn. J. Cancer Res., 82, 942-949 (1991).
21. Putter, J. and Becker, R. Peroxidase. In "Methods of Enzymatic Analysis, Vol. 3," ed. H.U. Bergmeyer, pp. 286-293 (1983). Verlag Chemie GmbH, Weinheim.
22. 51Cr-labeled allogeneic target cells in vitro. Immunology, 14, 181 196 (1968).
23. Ito, R. Über die spezifische entgiftende Wirkung der Farbstoffe der Trypanblaureihe auf das Streptolysin. Folia Pharmacol. Jpn., 30, 124-140 (1940) (in German).
24. Ikeda, S. Effect of hemolytic streptococci on induction of interferons in mouse spleen cells. J. Juzen Med. Soc., 92, 423-433 (1983) (in Japanese).
25. Halliwell, B. and Gutteridge, J. M. C. Oxygen is poisonous - an introduction to oxygen toxicity and free radicals. In "Free Radicals in Biology and Medicine," eds. B. Halliwell and J. M. C. Gutteridge, pp. 1-20 (1989). Clarendon Press, Oxford.
26. Starke, P. E. and Farber, J. L. Endogeneous defenses against the cytotoxicity of hydrogen peroxide in cultured rat hepatocytes. J. Biol. Chem., 260, 86-92 (1985).
27. Barchowsky, A., Kent, R. S. and Whorton, A. R. Recovery of porcine aortic endothelial cell prostaglandin synthesis following inhibitor by sublethal concentrations of hydrogen peroxide. Biochim. Biophys. Acta, 927, 372-381 (1987).
28. Schraufstatter, I. U., Hyslop, P. A., Hinshaw, D. B., Spragg, R. D., Sklar, L. A. and Cochrane, C. G. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly (ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA, 83, 4908-4912 (1986).
29. Geyer, R. P. Oxygen transport in vivo by means of perfluorochemical preparations. N. Engl J. Med., 307, 304-306 (1982).
30. Geyer, R. P. Fluorocarbon-polar artificial blood substitute. N. Engl. J. Med., 289, 1077 (1973).
31. Oldham, K. T., Guice, K. S., Gore, D., Gourly, W. K. and Lobe, T. E. Treatment of intestinal ischemia with oxygenated intraluminal perfluorocarbons. Am. J. Surg., 153, 291-294 (1987).
32. Del Monte, U. Change in oxygen tension in Yoshida ascites hepatoma during growth. Proc. Soc. Exp. Biol Med., 125, 853 (1967).
33. Vaupel, P., Kallinowski, F. and Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic, microenvironment of human tumors. Cancer Res., 49, 6449-6465 (1989).
34. Teicher, B. A., Holden, S. A. and Crawford, J. M. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice. Cancer, 61, 2196-2201 (1988).